Tocilizumab in Giant Cell Arteritis: Better Understanding the Benefits

Frank Buttgereit^*, Andriko Palmowski, Idil Esen, Elisabeth Brouwer

^*Corresponding author for this work

Research output: Contribution to journal › Editorial › Academic › peer-review

231 Downloads (Pure)

Access to Document

@article{e30f8976ef164cab800f71eba7bf6719,

title = "Tocilizumab in Giant Cell Arteritis: Better Understanding the Benefits",

author = "Frank Buttgereit and Andriko Palmowski and Idil Esen and Elisabeth Brouwer",

year = "2023",

month = apr,

doi = "10.1002/art.42414",

language = "English",

volume = "75",

journal = "Arthritis and Rheumatology",

issn = "2326-5191",

publisher = "Wiley",

number = "4",

}

TY - JOUR

T1 - Tocilizumab in Giant Cell Arteritis

T2 - Better Understanding the Benefits

AU - Buttgereit, Frank

AU - Palmowski, Andriko

AU - Esen, Idil

AU - Brouwer, Elisabeth

PY - 2023/4

Y1 - 2023/4

U2 - 10.1002/art.42414

DO - 10.1002/art.42414

M3 - Editorial

C2 - 36468520

AN - SCOPUS:85147276743

SN - 2326-5191

VL - 75

JO - Arthritis and Rheumatology

JF - Arthritis and Rheumatology

IS - 4

ER -